Benzamidine derivatives for treatment and prevention of cancer therapy induced mucositis

Details for Australian Patent Application No. 2006226390 (hide)

Owner Rottapharm S.p.A.

Inventors Artusi, Roberto; Caselli, Gianfranco; Zanzola, Simona; Rovati, Lucio Claudio; Giordani, Antonio; Letari, Ornella; D'amato, Massimo Maria

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006226390

PCT Pub. Number WO2006/100204

Priority 05102423.0 24.03.05 EP

Filing date 16 March 2006

Wipo publication date 28 September 2006

Acceptance publication date 8 September 2011

International Classifications

A61K 31/17 (2006.01) - having the group NC(O)N or NC(S)N, e.g. urea, thiourea, carmustine

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

Event Publications

4 October 2007 PCT application entered the National Phase

  PCT publication WO2006/100204 Priority application(s): WO2006/100204

8 September 2011 Application Accepted

  Published as AU-B-2006226390

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006226394-1-benzylindole-2-carboxamide derivatives

2006226381-Use of macrolides for treating intestinal inflammation